Outcomes in Patients with Classic Hodgkin Lymphoma Treated with ABVD: A Single-center Retrospective Study

OBJECTIVE: Classic Hodgkin lymphoma (CHL) has been regarded as a curable disease when treated appropriately, especially in younger patients, and ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) has been regarded as the standard regimen. However, a relatively poor prognosis has been report...

Descripción completa

Detalles Bibliográficos
Autores principales: Makiyama, Junya, Imaizumi, Yoshitaka, Watanabe, Haruka, Fujioka, Machiko, Chiwata, Masahiko, Kitanosono, Hideaki, Nakashima, Jun, Miyazaki, Yasushi, Yoshida, Shinichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990646/
https://www.ncbi.nlm.nih.gov/pubmed/33087662
http://dx.doi.org/10.2169/internalmedicine.5004-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990646/
https://www.ncbi.nlm.nih.gov/pubmed/33087662
http://dx.doi.org/10.2169/internalmedicine.5004-20

Ejemplares similares